quinaprilat has been researched along with Coronary Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, N; Drexler, H; Hornig, B | 1 |
Adnot, S; Belhassen, L; Benacerraf, S; Carville, C; Dubois-Randé, JL; Montagne, O; Sediame, S | 1 |
Baer, FM; Bol, A; Erdmann, E; Melin, J; Moka, D; Schicha, H; Schneider, CA; Sechtem, U; Voth, E; Wagner, R | 1 |
1 review(s) available for quinaprilat and Coronary Disease
Article | Year |
---|---|
Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Endothelium, Vascular; Heart Failure; Humans; Isoquinolines; Nitric Oxide; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation | 1998 |
2 trial(s) available for quinaprilat and Coronary Disease
Article | Year |
---|---|
Improvement of bradykinin endothelium-mediated vasodilation of forearm resistance circulation by quinaprilat in patients with coronary artery disease with or without left ventricular dysfunction.
Topics: Acetylcholine; Adult; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Bradykinin; Coronary Angiography; Coronary Disease; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Forearm; Humans; Isoquinolines; Male; Middle Aged; Platelet Aggregation Inhibitors; Regional Blood Flow; Renin; Tetrahydroisoquinolines; Vasodilation; Vasomotor System; Ventricular Dysfunction, Left | 1999 |
Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Dobutamine; Exercise Test; Female; Humans; Isoquinolines; Male; Middle Aged; Prospective Studies; Tetrahydroisoquinolines; Tomography, Emission-Computed; Treatment Outcome; Vascular Resistance | 1999 |